Skip to main content
. 2014 Oct;7(7 suppl3):S36–S47.

Figure 2. JAK2 and Other Mutations in Patients with Myeloproliferative Neoplasms.

Figure 2

PV indicates polycythemia vera; ET, essential thrombocythemia; PMF, Philadelphia-negative myeloproliferative neoplasm.

Sources: Spivak JL. Blood. 2002;100:4272–4290; Levine RL, et al. Nat Rev Cancer. 2007;7:673–683; Oh ST. Ther Adv Hematol. 2011;2:11-19; Vannucchi AM, et al. Haematologica. 2008;93:972–976.